May 29th, 2008 – Brocair Partners LLC, an investment banking firm serving the healthcare industry, recently chaired a panel at TiECON East on focused on Cross Border M&A in BioPharma.
Members of the Panel also included Johannes Burlin, President & CEO, Advanced Bioscience Laboratories; Vipin Garg, President & CEO, Tranzyme Pharmaceuticals; Ajit Mahadevan, Partner, Business Advisory Services, Ernst & Young Pvt. Ltd.; and Bruce Raphael, Partner, Edwards, Angell, Palmer & Dodge.
Rusty Ray, Partner at Brocair Partners explained, "I think the panel was able to offer the audience a wide array of experiences as they relate to cross-border transactions. The discussions around the mechanics of completing a multi-national transaction were well received; the points addressed included how to avoid legal pitfalls, ensuring financing, and structuring the deal. While the audience found those aspects of cross-border M&A interesting, I believe it was the discussion on the softer elements of these transactions that made the most impact on the audience, such as addressing cultural differences and the successful integration of varied business models."
"Overall, it was a terrific opportunity to share some of our own experiences and compare notes with colleagues who have worked in varying capacities on multinational deals. The TiECON East conference was a terrific venue for the exchange of those kinds of ideas."
TiE is a global not-for-profit organization with a mission to foster and support entrepreneurship. It is an active, vibrant organization with 48 chapters in 15 countries with over 12,000 members globally. TiE represents a diverse set of industries, including software and information technologies, biotech, financial services and other services.